As filed with the Securities and Exchange
Commission on March 15, 2019
Registration No. 333-_______
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, DC 20549
FORM S-3
REGISTRATION STATEMENT UNDER
THE SECURITIES ACT OF 1933
Bridge
Bancorp, Inc.
(Exact name of registrant as specified in its charter)
New York
(State or other jurisdiction of incorporation
or organization)
11-2934195
(I.R.S. Employer Identification No.)
2200 Montauk Highway, Bridgehampton,
New York 11932, (631) 537-1000
(Address, including zip code, and telephone
number, including area code, of registrant’s principal executive office)
Kevin M. O’Connor
President and Chief Executive Officer
Bridge Bancorp, Inc.
2200 Montauk Highway
Bridgehampton, New York 11932
(631) 537-1000
(Name, address, including zip code, and
telephone number, including area code, of agent for service)
Copies of all communications to:
John J. Gorman, Esq.
Luse Gorman, PC
5335 Wisconsin Avenue, N.W., Suite 780
Washington, D.C. 20015
Approximate date of commencement of
proposed sale to the public:
From time to time after the effective date of this registration statement.
If
the only securities being registered on this Form are being offered pursuant to dividend or interest reinvestment plans, please
check the following box.
¨
If any of the securities being registered
on this Form are to be offered on a delayed or continuous basis pursuant to Rule 415 under the Securities Act of 1933, other than
securities offered only in connection with dividend or interest reinvestment plans, check the following box.
x
If
this Form is filed to register additional securities for an offering pursuant to Rule 462(b) under the Securities Act, please check
the following box and list the Securities Act registration statement number of the earlier effective registration statement for
the same offering.
¨
If
this Form is a post-effective amendment filed pursuant to Rule 462(c) under the Securities Act, check the following box and list
the Securities Act registration statement number of the earlier effective registration statement for the same offering.
¨
If
this Form is a registration statement pursuant to General Instruction I.D. or a post-effective amendment thereto that shall become
effective upon filing with the Commission pursuant to Rule 462(e) under the Securities Act, check the following box.
¨
If
this Form is a post-effective amendment to a registration statement filed pursuant to General Instruction I.D. filed to register
additional securities or additional classes of securities pursuant to Rule 413(b) under the Securities Act, check the following
box.
¨
Indicate
by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting
company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,”
“smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.
|
Large accelerated filer
¨
|
Accelerated filer
x
|
|
|
Non-accelerated filer
¨
|
Smaller reporting company
¨
|
Emerging growth company
¨
|
If an emerging growth
company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any
new or revised financial accounting standards provided pursuant to Section 7(a)(2)(B) of the Securities Act.
¨
CALCULATION OF REGISTRATION FEE
|
Title of each Class of
Securities to be Registered
|
|
Amount
to be
Registered
(1)(2)(3)
|
|
|
Proposed
Maximum
Offering Price
Per Unit
(1)
|
|
|
Proposed Maximum
Aggregate
Offering Price
(1)(2)(3)
|
|
|
Amount of
Registration
Fee
|
|
|
Debt Securities
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Common Stock, $0.01 par value per share
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Preferred Stock, $0.01 par value per share
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Depository Shares
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Warrants
(4)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Purchase Contracts
(5)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Units
(6)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Subscription Rights
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total
|
|
$
|
200,000,000
|
|
|
|
|
|
|
$
|
200,000,000
|
|
|
$
|
24,240
|
(7)
|
|
|
(1)
|
Information as to each class of security has been omitted pursuant to General Instruction II.D of Form S-3 under the Securities
Act.
|
|
|
(2)
|
The Registrant is hereby registering an indeterminate principal amount and number of each identified class of its securities
up to a proposed maximum aggregate offering price of $200,000,000, which may be offered from time to time in unspecified numbers
at unspecified prices. The Registrant has estimated the proposed maximum aggregate offering price solely for the purpose of calculating
the registration fee pursuant to Rule 457(o) under the Securities Act. Securities registered hereunder may be sold separately,
together or as units with other securities registered hereunder.
|
|
|
(3)
|
The Registrant is hereby registering such indeterminate amount and number of each identified class of the identified securities
as may be issued upon conversion, exchange, or exercise of any other securities that provide for such conversion, exchange or exercise.
|
|
|
(4)
|
Warrants may be sold separately or together with our debt securities, preferred stock, common stock or depositary shares. Includes
an indeterminate number of our debt securities, shares of preferred stock, shares of common stock or depositary shares to be issuable
upon the exercise of warrants for such securities.
|
|
|
(5)
|
Includes an indeterminate number of our common stock, preferred stock, debt securities or depositary shares that we may be
obligated to sell or purchase from the holders at a future date or future dates.
|
|
|
(6)
|
Each unit will be issued under a unit agreement and will represent an interest in two or more other securities, which may or
may not be separable from one another.
|
|
|
(7)
|
In accordance with Rule 457(p), $15,104 has already been paid with respect to $149,997,000 aggregate initial offering price
of securities that were previously registered pursuant to registration statement No. 333-210245, initially filed by Bridge Bancorp,
Inc. on March 16, 2016 and declared effective on April 22, 2016 (the “Prior Registration Statement”), and not sold
thereunder. Under the Prior Registration Statement, the registrant registered an aggregate amount of $200,000,000 of securities
and paid an aggregate filing fee of $20,140 for the securities registered under the Prior Registration Statement. Of the $200,000,000
aggregate amount of securities registered under the Prior Registration Statement, $149,997,000 remain unissued, which unissued
securities are hereby deregistered. Accordingly, pursuant to Rule 457(p) under the Securities Act of 1933, as amended, the registrant
is entitled to offset, against the filing fee due for this Registration Statement, $15,104 of the Prior Registration Statement
filing fee paid with respect to the unissued securities under the Prior Registration Statement (calculated at the rate in effect
at the time the Prior Registration Statement was filed).
|
The Registrant hereby amends this registration statement
on such date or dates as may be necessary to delay its effective date until the Registrant shall file a further amendment which
specifically states that this registration statement shall thereafter become effective in accordance with Section 8(a) of the Securities
Act of 1933 or until the registration statement shall become effective on such date as the Commission, acting pursuant to said
Section 8(a), may determine.
The information in this
prospectus is not complete and may be changed. A registration statement relating to these securities has been filed with the Securities
and Exchange Commission and has not yet been declared effective. The securities may not be sold until the registration statement
has been declared effective. This prospectus is not an offer to sell these securities and it is not soliciting an offer to buy
these securities in any state where the offer or sale is not permitted.
SUBJECT TO COMPLETION,
DATED MARCH 15, 2019
PROSPECTUS
$200,000,000
Debt Securities
Common Stock
Preferred Stock
Depository Shares
Warrants
Purchase Contracts
Units
Subscription Rights
We may offer and sell from time to time
up to $200.0 million of unsecured debt securities, which may consist of notes, debentures, or other evidences of indebtedness;
shares of common stock; shares of preferred stock; depositary shares; purchase contracts; warrants to purchase other securities;
units consisting of any combination of the above securities; or subscription rights to purchase common stock, preferred stock,
depositary shares or debt securities that we may offer to our stockholders. This prospectus provides you with a general description
of the securities listed above. Each time we offer any securities pursuant to this prospectus, we will provide you with a prospectus
supplement, and, if necessary, a pricing supplement, that will describe the specific amounts, prices and terms of the securities
being offered. These supplements may also add, update or change information contained in this prospectus. To understand the terms
of the securities offered, you should carefully read this prospectus with the applicable supplements, which together provide the
specific terms of the securities we are offering.
Our common stock is traded on the Nasdaq
Global Select Market under the symbol “BDGE.”
This prospectus may be used to offer and
sell securities only if accompanied by the prospectus supplement and any applicable pricing supplement for those securities.
You should read this prospectus and
any supplements carefully before you invest. Investing in our securities involves a high degree of risk. See the sections entitled
“Risk Factors,” on page 3 of this prospectus, in any prospectus supplement and in the documents we file with the Securities
and Exchange Commission that are incorporated in this prospectus by reference for a discussion of certain risks and uncertainties
you should consider.
These securities are not deposits or
obligations of a bank or savings association and are not insured or guaranteed by the Federal Deposit Insurance Corporation or
any other governmental agency.
Neither the Securities and Exchange
Commission nor any state securities commission has approved or disapproved of these securities or determined that this prospectus
or any prospectus supplement is truthful or complete. Any representation to the contrary is a criminal offense.
The date of this prospectus is ,
2019.
IMPORTANT NOTICE ABOUT INFORMATION PRESENTED
IN THIS
PROSPECTUS AND THE ACCOMPANYING PROSPECTUS
SUPPLEMENT
We may provide information to you about
the securities we are offering in three separate documents that progressively provide more detail:
|
|
•
|
this prospectus, which provides general information about
Bridge Bancorp, Inc. and the securities being registered, some of which may not apply to your securities;
|
|
|
•
|
a prospectus supplement, which describes the terms of
a particular issuance of securities, some of which may not apply to your securities and which may not include information relating
to the prices of the securities being offered; and
|
|
|
•
|
if necessary, a pricing supplement, which describes the
pricing terms of your securities.
|
If the terms of your securities vary among
the pricing supplement, the prospectus supplement and the prospectus, you should rely on the information in the following order
of priority:
|
|
•
|
the pricing supplement, if any;
|
|
|
•
|
the prospectus supplement; and
|
We include cross-references in this prospectus
and the prospectus supplement to captions in these materials where you can find further related discussions. The following Table
of Contents and the Table of Contents included in the prospectus supplement provide the pages on which these captions are located.
Unless indicated in the applicable prospectus
supplement, we have not taken any action that would permit us to publicly sell these securities in any jurisdiction outside the
United States. If you are an investor outside the United States, you should inform yourself about and comply with any restrictions
as to the offering of the securities and the distribution of this prospectus.
TABLE OF CONTENTS
ABOUT THIS PROSPECTUS
This prospectus is part of a registration
statement that we filed with the Securities and Exchange Commission (the “SEC”) utilizing a “shelf” registration
process. Under this shelf registration process, we may from time to time offer and sell the debt securities; common stock; preferred
stock; depositary shares; warrants; purchase contracts; units consisting of any combination of the above securities; or subscription
rights to purchase common stock, preferred stock, depositary shares or debt securities that we may offer to our stockholders, in
each case up to a total dollar amount of $200.0 million. This prospectus provides you with a general description of the securities
covered by it. Each time we offer these securities, we will provide a prospectus supplement and, if necessary, a pricing supplement,
that will contain specific information about the terms of the offer. The prospectus supplement and any pricing supplement may also
add, update or change information contained in this prospectus. You should read this prospectus, the prospectus supplement and
any pricing supplement together with the additional information described under the heading
“Where You Can Find More Information.”
Unless otherwise indicated or unless the
context requires otherwise, all references in this prospectus to “Bridge Bancorp,” the “Company,” “we,”
“us,” “our” or similar references mean Bridge Bancorp, Inc., and references to the “Bank” mean
BNB Bank.
WHERE YOU CAN FIND MORE INFORMATION
We file periodic and current reports,
proxy statements and other documents with the SEC. The SEC maintains a website that contains these reports, proxy statements and
other documents, and other information regarding issuers that make electronic filings with the SEC. You may read any document we
file on the SEC’s Internet site at
http://www.sec.gov
.
This prospectus is part of a registration
statement that we filed with the SEC. The registration statement contains more information than this prospectus regarding us, including
certain exhibits and schedules. You can obtain a copy of the registration statement from the SEC’s website.
INCORPORATION OF CERTAIN DOCUMENTS BY
REFERENCE
The SEC allows us to “incorporate
by reference” information into this prospectus. This means that we can disclose important information to you by referring
you to another document that we file separately with the SEC. The information incorporated by reference is considered to be a part
of this prospectus, except for any information that is superseded by information that is included directly in this document or
in a more recent incorporated document.
This prospectus incorporates by reference
the documents listed below that we have previously filed with the SEC.
|
SEC Filings
|
|
Period or Filing Date (as applicable)
|
|
|
|
|
|
Annual Report on Form 10-K
|
|
Year ended December 31, 2018
|
|
|
|
|
|
Current Reports on Form 8-K (in each case other than those portions furnished under Item 2.02 or 7.01 of Form 8-K)
|
|
January 7, 2019, January 18, 2019 and February 19, 2019
|
|
|
|
|
|
The description of our common stock set forth in the registration statement on Form 8-A12B (No. 001-34096) and any amendment or report filed with the SEC for the purpose of updating this description
|
|
June 9, 2008
|
In addition, we also incorporate by reference
all future documents that we file with the SEC under Sections 13(a), 13(c), 14 or 15(d) of the Exchange Act after the date of our
initial registration statement relating to the securities covered by this prospectus until the completion of the distribution of
such securities. These documents include periodic reports, such as annual reports on Form 10-K and quarterly reports on Form 10-Q,
and current reports on Form 8-K (other than current reports furnished under Items 2.02 or 7.01 of Form 8-K), as well as proxy statements.
The information incorporated by reference
contains information about us and our financial condition and is an important part of this prospectus.
You can obtain any of the documents incorporated by reference
in this document through us, or from the SEC through the SEC’s Internet site at
www.sec.gov
. Documents incorporated
by reference are available from us without charge, excluding any exhibits to those documents, unless the exhibit is specifically
incorporated by reference as an exhibit in this prospectus. You can obtain documents incorporated by reference in this prospectus
from us by requesting them in writing or by telephone using the following contact information:
Corporate Secretary
Bridge Bancorp, Inc.
(631) 537-1000
|
Overnight Mail
|
Regular Mail
|
|
Corporate Secretary
|
Corporate Secretary
|
|
Bridge Bancorp, Inc.
|
Bridge Bancorp, Inc.
|
|
2200 Montauk Highway
|
P.O. Box 3005
|
|
Bridgehampton, New York 11932
|
Bridgehampton, New York 11932
|
In addition, we maintain a corporate website,
www.bnbbank.com
. We make available, through our website, our annual reports on Form 10-K, quarterly reports on Form 10-Q,
current reports on Form 8-K, and any amendments to those reports filed or furnished pursuant to Section 13(a) or 15(d) of the Securities
Exchange Act of 1934, or the Exchange Act, as soon as reasonably practicable after we electronically file such material with, or
furnish it to, the SEC. This reference to our website is for the convenience of investors as required by the SEC and shall not
be deemed to incorporate any information on the website into this Registration Statement.
We have not authorized anyone to give any
information or make any representation about us that is different from, or in addition to, those contained in this prospectus or
in any of the materials that we have incorporated into this prospectus. If anyone does give you information of this sort, you should
not rely on it. If you are in a jurisdiction where offers to sell, or solicitations of offers to purchase, the securities offered
by this document are unlawful, or if you are a person to whom it is unlawful to direct these types of activities, then the offer
presented in this document does not extend to you. The information contained in this document speaks only as of the date of this
document unless the information specifically indicates that another date applies.
SPECIAL NOTE REGARDING FORWARD-LOOKING
STATEMENTS
This prospectus and
the documents incorporated into it by reference may contain statements that are considered “forward-looking statements,”
as defined in the Private Securities Litigation Reform Act of 1995 (the “PSLRA”). Such forward-looking statements,
in addition to historical information, involve risk and uncertainties, and are based on the beliefs, assumptions and expectations
of management of the Company. Words such as “expects,” “believes,” “should,” “plans,”
“anticipates,” “will,” “potential,” “could,” “intend,” “may,”
“outlook,” “predict,” “project,” “would,” “estimated,” “assumes,”
“likely,” and variation of such similar expressions are intended to identify such forward-looking statements. Examples
of forward-looking statements include, but are not limited to, possible or assumed estimates with respect to the financial condition,
expected or anticipated revenue, and results of operations and business of the Company, including earnings growth; revenue growth
in retail banking, lending and other areas; origination volume in the consumer, commercial and other lending businesses; current
and future capital management programs; non-interest income levels, including fees from the title abstract subsidiary and banking
services as well as product sales; tangible capital generation; market share; expense levels; and other business operations and
strategies.
Forward-looking statements
speak only as of the date they are made. Because forward-looking statements are subject to assumptions and uncertainties, actual
results or future events could differ, possible materially, from those that we anticipated in our forward-looking statements and
future results could differ materially from historical performance. Factors that could cause future results to vary from current
management expectations as reflected in our forward-looking statements include, but are not limited to, changing economic conditions;
legislative and regulatory changes, including increases in Federal Deposit Insurance Corporation (“FDIC”) insurance
rates; monetary and fiscal policies of the federal government; changes in tax policies; rates and regulations of federal, state
and local tax authorities; changes in accounting principles, changes in interest rates; deposit flows; the cost of funds; inflation;
demands for loan products; demand for financial services; changes in consumer spending; competition; changes in real estate values;
changes in the securities markets; changes in the quality and composition of the Bank’s loan and investment portfolios; changes
in management’s business strategies; our ability to manage market risk, credit risk and operational risk; our ability to
enter new markets successfully; our ability to successfully integrate acquired businesses; our ability to retain key employees;
and other factors discussed elsewhere in this report, and in other reports filed by the Company with the Securities and Exchange
Commission.
You should not place
undue reliance on these forward-looking statements, which reflect our expectations only as of the date of this prospectus. We do
not assume any obligation to revise forward-looking statements except as may be required by law.
RISK FACTORS
Before making an investment decision,
you should carefully consider the risks described under
“Risk Factors”
in the applicable prospectus supplement
and in our most recent Annual Report on Form 10-K, and in our updates to those Risk Factors in our Quarterly Reports on Form 10-Q,
together with all of the other information appearing in this prospectus or incorporated by reference into this prospectus, the
prospectus supplement or any applicable pricing supplement, in light of your particular investment objectives and financial circumstances.
In addition to those risk factors, there may be additional risks and uncertainties of which management is not aware or focused
on or that management deems immaterial. Our business, financial condition or results of operations could be materially adversely
affected by any of these risks. The trading price of our securities could decline due to any of these risks, and you may lose all
or part of your investment.
OUR COMPANY
Bridge Bancorp, Inc.
is a New York corporation formed in 1988 to become the holding company for BNB Bank. We are registered as a bank holding company
under the Bank Holding Company Act of 1956, as amended. At December 31, 2018, we had total assets of $4.7 billion, deposits of
$3.9 billion and total stockholders’ equity of $453.8 million.
BNB Bank was established as “The
Bridgehampton National Bank” in 1910 as a national banking association and is headquartered in Bridgehampton, New York.
In December 2017, the Bank converted its charter to that of a New York commercial bank. The Bank operates 39 branch offices
in its primary market area of Suffolk and Nassau Counties on Long Island, New York and the New York City boroughs of Queens
and Manhattan. In addition, the Bank operates one loan production office in Manhattan. Through this network and its
electronic delivery channels, the Bank provides deposit and loan products and financial services to local businesses,
consumers and municipalities. In addition, the Bank offers merchant credit and debit card processing, automated teller
machines, cash management services, lockbox processing, online banking services, remote deposit capture, safe deposit boxes,
and individual retirement accounts as well as investment services through Bridge Financial Services, which offers a full
range of investment products and services through a third-party broker dealer. Through its title insurance
abstract subsidiary, the Bank acts as a broker for title insurance services. The Bank’s customer base is comprised
principally of small businesses, municipal relationships and consumer relationships.
Our executive offices
are located at 2200 Montauk Highway, Bridgehampton, New York 11932, and our telephone number is (631) 537-1000.
Additional information about us and our
subsidiaries is included in documents incorporated by reference in this prospectus. See
“Where You Can Find More Information”
and
“Incorporation of Certain Documents by Reference”
on page 1 of this prospectus.
REGULATION AND SUPERVISION
As a bank holding company controlling the
Bank, we are subject to the Bank Holding Company Act of 1956, as amended (“BHCA”), and the rules and regulations of
the Board of Governors of the Federal Reserve System (“Federal Reserve Board”) under the BHCA applicable to bank holding
companies. We are required to file reports with, and otherwise comply with the rules and regulations of the Federal Reserve Board
and the SEC.
Our banking subsidiary, BNB Bank, is a
New York-chartered commercial bank and a member of the Federal Reserve System. The lending, investment, and other business operations
of the Bank are governed by New York and federal laws and regulations, and the Bank is prohibited from engaging in any operations
not specifically authorized by such laws and regulations. The Bank is subject to extensive regulation by the New York State Department
of Financial Services (“NYSDFS”) and, as a member bank, by the Board of Governors of the Federal Reserve System (“FRB”).
The Bank’s deposit accounts are insured up to applicable limits by the FDIC under its Deposit Insurance Fund (“DIF”)
and the FDIC has certain regulatory authority as deposit insurer. A summary of the primary laws and regulations that govern the
operations of the Bank are set forth below.
These regulatory authorities have extensive
enforcement authority over the institutions that they regulate to prohibit or correct activities that violate law, regulation or
a regulatory agreement or which are deemed to be unsafe or unsound banking practices. Enforcement actions may include the appointment
of a conservator or receiver, the issuance of a cease and desist order, the termination of deposit insurance, the imposition of
civil money penalties on the institution, its directors, officers, employees and institution-affiliated parties, the issuance of
directives to increase capital, the issuance of formal and informal agreements, the removal of or restrictions on directors, officers,
employees and institution-affiliated parties, and the enforcement of any such mechanisms through restraining orders or other court
actions. Any change in laws and regulations, whether by the State of New York, the FDIC, the Federal Reserve Board or through legislation,
could have a material adverse impact on us, our operations and our stockholders.
Because we are a holding company, our rights
and the rights of our creditors and the holders of the securities we are offering under this prospectus to participate in the assets
of any of our subsidiaries upon the subsidiary’s liquidation or reorganization will be subject to the prior claims of the
subsidiary’s creditors, except to the extent that we may ourselves be a creditor with recognized claims against the subsidiary.
In addition, dividends, loans and advances
from the Bank to us are restricted by federal law.
For a discussion of the material elements
of the regulatory framework applicable to bank holding companies and their subsidiaries, and specific information relevant to us
and the Bank, you should refer to our Annual Report on Form 10-K for the year ended December 31, 2018, and any other subsequent
reports filed by us with the SEC, which are incorporated by reference in this prospectus. This regulatory framework is intended
primarily for the protection of depositors and the Deposit Insurance Fund that insures deposits of the Bank, rather than for the
protection of security holders.
USE OF PROCEEDS
The Company intends
to use the net proceeds from the sale of any securities offered under this prospectus in the manner and for the purposes set forth
in the applicable prospectus supplement.
DESCRIPTION OF THE SECURITIES
This prospectus contains a summary of
the debt securities, common stock, preferred stock, depositary shares, warrants, purchase contracts, units and subscription rights
that may be offered under this prospectus. The following summaries are not meant to be a complete description of each security.
The prospectus supplement and the pricing supplement, if applicable, contain the material terms and conditions for each security.
You should read all of these documents as well as the documents filed as exhibits to or incorporated by reference to this registration
statement. Capitalized terms used in this prospectus that are not defined will have the meanings given them in these documents.
Description of Debt Securities
General
We may issue senior debt securities or
subordinated debt securities. Senior debt securities will be issued under an indenture, referred to as the “senior indenture,”
and subordinated debt securities will be issued under a separate indenture, referred to in this section as the “subordinated
indenture.” The senior indenture and the subordinated indenture are referred to in this section as the “indentures.”
The senior debt securities and the subordinated debt securities are referred to in this section as the “debt securities.”
The debt securities will be our direct unsecured general obligations.
This prospectus describes the general
terms and provisions of the debt securities. When we offer to sell a particular series of debt securities, we will describe the
specific terms of the securities in a supplement to this prospectus. The prospectus supplement will also indicate whether the general
terms and provisions described in this prospectus apply to a particular series of debt securities.
The following briefly describes the general
terms and provisions of the debt securities and the indentures. We have not restated these indentures in their entirety in this
description. We have filed the forms of the indentures, including the forms of debt securities, as exhibits to the registration
statement of which this prospectus is a part. We urge you to read the indentures, because they, and not this description, control
your rights as holders of the debt securities. The following description of the indentures is not complete and is subject to, and
qualified in its entirety by reference to, all the provisions in the respective indentures. In the summary below, we have included
references to section numbers of the applicable indenture so that you can easily locate these provisions. Capitalized terms used
in the summary have the meanings specified in the indentures.
Neither indenture limits the amount of debt
securities that we may issue under the indenture from time to time in one or more series. We may in the future issue debt securities
under either indenture. At the date of this prospectus, we had not issued any debt securities under either indenture.
Neither indenture contains provisions that
would afford holders of debt securities protection in the event of a sudden and significant decline in our credit quality or a
takeover, recapitalization or highly leveraged or similar transaction. Accordingly, we could in the future enter into transactions
that could increase the amount of indebtedness outstanding at that time or otherwise adversely affect our capital structure or
credit rating.
The debt securities will be our exclusive
obligations. Neither indenture requires our subsidiaries to guarantee the debt securities. As a result, the holders of debt securities
will generally have a junior position to claims of all creditors and preferred shareholders of our subsidiaries.
Terms of Each Series of Debt Securities Provided in the Prospectus
Supplement
A prospectus supplement and any supplemental
indenture relating to any series of debt securities being offered will include specific terms relating to the offering. These terms
will include some or all of the following (Section 301):
|
|
•
|
the form and title of the debt securities;
|
|
|
•
|
whether the debt securities are senior debt securities
or subordinated debt securities and the terms of subordination;
|
|
|
•
|
the principal amount of the debt securities;
|
|
|
•
|
the denominations in which the debt securities will be
issued;
|
|
|
•
|
the portion of the principal amount which will be payable
if the maturity of the debt securities is accelerated;
|
|
|
•
|
the currency or currency unit in which the debt securities
will be paid, if not U.S. dollars;
|
|
|
•
|
any right we may have to defer payments of interest by
extending the dates payments are due and whether interest on those deferred amounts will be payable as well;
|
|
|
•
|
the place where the principal of, and premium, if any,
and interest on any debt securities will be payable;
|
|
|
•
|
the date or dates on which the debt securities will be
issued and the principal, and premium, if any, of the debt securities will be payable;
|
|
|
•
|
the rate or rates which the debt securities will bear
interest and the interest payment dates for the debt securities;
|
|
|
•
|
any mandatory or optional redemption provisions;
|
|
|
•
|
the terms, if any, upon which the debt securities are
convertible into other securities of ours and the terms and conditions upon which any conversion will be effected, including the
initial conversion price or rate, the conversion period and any other provisions in addition to or instead of those described
in this prospectus;
|
|
|
•
|
any sinking fund or other provisions that would obligate
us to repurchase or otherwise redeem the debt securities;
|
|
|
•
|
any deletion from, changes of or additions to the covenants
or the Events of Default (as defined below) under “
Provisions in Both Indentures – Events of Default and Remedies
”;
|
|
|
•
|
any changes to the terms and condition upon which the
debt securities can be defeased or discharged;
|
|
|
•
|
any restriction or other provision with respect to the
transfer or exchange of the debt securities;
|
|
|
•
|
the identity of any other trustee, paying agent and security
registrar, if other than the trustee; and
|
|
|
•
|
any other terms of the debt securities.
|
We will maintain in each place specified
by us for payment of any series of debt securities an office or agency where debt securities of that series may be presented or
surrendered for payment, where debt securities of that series may be surrendered for registration of transfer or exchange and where
notices and demands to or upon us in respect of the debt securities of that series and the related indenture may be served (Section
1002).
Debt securities may be issued under an indenture
as original issue discount securities to be offered and sold at a substantial discount below their principal amount. Material federal
income tax, accounting and other considerations applicable to any such original issue discount securities will be described in
any related prospectus supplement. “Original issue discount security” means any security which provides for an amount
less than the principal amount thereof to be due and payable upon a declaration of acceleration of the maturity thereof as a result
of the occurrence of an Event of Default and the continuation thereof (Section 101).
Provisions Only in the Senior Indenture
Payment of the principal, premium, if any,
and interest on the senior debt securities will rank equally in right of payment with all of our other unsecured senior debt.
Provisions Only in the Subordinated Indenture
Payment of the principal, premium, if any,
and interest on the subordinated debt securities will be subordinate and junior in priority of payment to prior payment in full
of all of our senior indebtedness, including senior debt securities and other debt to the extent described in a prospectus supplement
(Section 1401 of the subordinated indenture).
Subordinated Debt Securities Intended to Qualify as Tier
2 Capital
Unless otherwise stated in the applicable
prospectus supplement, it is currently intended that the subordinated debt securities will qualify as Tier 2 Capital under the
guidelines established by the Federal Reserve Board for bank holding companies. The guidelines set forth specific criteria for
subordinated debt to qualify as Tier 2 Capital. Among other things, the subordinated debt must:
|
|
•
|
have an average maturity of at least five years;
|
|
|
•
|
be subordinated in right of payment;
|
|
|
•
|
not contain provisions permitting the holders of the debt to accelerate payment of principal prior to maturity except in the
event of bankruptcy of the issuer;
|
|
|
•
|
not contain provisions permitting the issuer of the debt to redeem the security prior to the maturity date without prior approval
of the Federal Reserve; and
|
|
|
•
|
not contain provisions that would adversely affect liquidity or unduly restrict management’s flexibility to operate the
organization, particularly in times of financial difficulty, such as limitations on additional secured or senior borrowings, sales
or dispositions of assets or changes in control.
|
Provisions in Both Indentures
Consolidation, Merger or Asset Sale
Each indenture generally allows us to consolidate
or merge with a domestic person, association or entity. Each also allows us to sell, lease or transfer our property and assets
substantially as an entirety to a domestic person, association or entity. If this happens, the remaining or acquiring person, association
or entity must assume all of our responsibilities and liabilities under the indentures including the payment of all amounts due
on the debt securities and performance of the covenants in the indentures.
However, we will only consolidate or merge
with or into any other person, association or entity or sell, lease or transfer our assets substantially as an entirety according
to the terms and conditions of the indentures, which require that:
|
|
•
|
the remaining or acquiring person, association or entity is organized under the laws of the United States, any state within
the United States or the District of Columbia;
|
|
|
•
|
the remaining or acquiring person, association or entity assumes our obligations under the indentures; and
|
|
|
•
|
immediately after giving effect to the transaction, no Default or Event of Default, as defined below, shall have occurred and
be continuing.
|
The remaining or acquiring person, association
or entity will be substituted for us in the indentures with the same effect as if it had been an original party to the indentures.
Thereafter, the successor may exercise our rights and powers under the indentures, in our name or in its own name. If we sell or
transfer all or substantially all of our assets, we will be released from all our liabilities and obligations under any indenture
and under the debt securities. If we lease all or substantially all of our assets, we will not be released from our obligations
under the indentures (Sections 801 and 802).
Events of Default and Remedies
In the indentures, Default with respect
to any series of debt securities means any event which is, or after notice or lapse of time or both would become, an Event of Default.
In the indentures, Event of Default with
respect to any series of debt securities means any of the following (Section 501):
|
|
•
|
failure to pay the principal of or any premium on any debt security of that series when due;
|
|
|
•
|
failure to pay interest on any debt security of that series for 30 days;
|
|
|
•
|
subject to certain exceptions, failure to perform any other covenant in the indenture, other than a covenant default in the
performance of which has expressly been included in the indenture solely for the benefit of series of debt securities other than
that series, that continues for 90 days after being given written notice as specified in the indenture;
|
|
|
•
|
our bankruptcy, insolvency or reorganization; or
|
|
|
•
|
any other Event of Default included in any indenture or supplemental indenture.
|
If an Event of Default with respect to a
series of debt securities occurs and is continuing, the trustee or the holders of at least 25% in principal amount of all of the
outstanding debt securities of a particular series may declare the principal of all the debt securities of that series to be due
and payable. When such declaration is made, such amounts will be immediately due and payable. The holders of a majority in principal
amount of the outstanding debt securities of such series may rescind such declaration and its consequences if all existing Events
of Default have been cured or waived, other than nonpayment of principal or interest that has become due solely as a result of
acceleration (Section 502).
Holders of a series of debt securities may
not enforce the indenture or the series of debt securities, except as provided in the indenture or a series of debt securities
(Section 507). The trustee may require indemnity satisfactory to it before it enforces the indenture or such series of debt securities
(Section 603). Subject to certain limitations, the holders of a majority in principal amount of the outstanding debt securities
of a particular series may direct the time, method and place of conducting any proceeding for any remedy available to the trustee
or exercising any trust or power of the trustee (Section 512). The trustee may withhold notice to the holders of debt securities
of any default, except in the payment of principal or interest, if it considers such withholding of notice to be in the best interests
of the holders (Section 602).
An Event of Default for a particular series
of debt securities does not necessarily constitute an Event of Default for any other series of debt securities issued under an
indenture. Further, an Event of Default under the debt securities of any series will not necessarily constitute an event of default
under our other indebtedness or vice versa.
Modification of Indentures
Under each indenture, generally we and the
trustee may modify our rights and obligations and the rights of the holders with the consent of the holders of a majority in aggregate
principal amount of the outstanding debt securities of any series affected by the modification, voting as one class. No modification
of the principal or interest payment terms, requirement that the Company maintain an office or agency for matters related to the
debt securities, reduction of the percentage consent required for modifications, or impairment of the right to institute suit for
the payment on debt securities of any series when due, is effective against any holder without consent of all holders (Section
902).
In addition, we and the trustee may enter
into supplemental indentures without the consent of any holder of the debt securities to make certain technical changes, such as
(Section 901):
|
|
•
|
curing ambiguities or correcting defects or inconsistencies;
|
|
|
•
|
evidencing the succession of another person to us, and the assumption by that successor of our obligations under the applicable
indenture and the debt securities of any series;
|
|
|
•
|
providing for a successor trustee;
|
|
|
•
|
qualifying the indentures under the Trust Indenture Act of 1939, as amended (the “Trust Indenture Act”); or
|
|
|
•
|
complying with the rules and regulations of any securities exchange or automated quotation system on which debt securities
of any series may be listed or traded.
|
Discharging Our Obligations
We may choose either to discharge our obligations
on the debt securities of any series in a legal defeasance, or to release ourselves from our covenant restrictions on the debt
securities of any series in a covenant defeasance. We may do so at any time on the 91st day after we deposit with the trustee sufficient
cash or government securities to pay the principal, interest, any premium and any other sums due to the stated maturity date or
a redemption date of the debt securities of the series. If we choose the legal defeasance option, the holders of the debt securities
of the series will not be entitled to the benefits of the indenture except for registration of transfer and exchange of debt securities,
replacement of lost, stolen or mutilated debt securities, conversion or exchange of debt securities, sinking fund payments and
receipt of principal and interest on the original stated due dates or specified redemption dates (Section 1302).
We may discharge our obligations on the
debt securities of any series or release ourselves from covenant restrictions only if we meet certain requirements. Among other
things, we must deliver an opinion of our legal counsel that the discharge will not result in holders having to recognize taxable
income or loss or subject them to different tax treatment. In the case of legal defeasance, this opinion must be based on either
an IRS letter ruling or change in federal tax law. We may not have a default on the debt securities discharged on the date of deposit.
The discharge may not violate any of our agreements. The discharge may not result in our becoming an investment company in violation
of the Investment Company Act of 1940.
Information Concerning the Indenture Trustee
Under provisions of the indentures and the
Trust Indenture Act, if a trustee has or shall acquire a conflicting interest within the meaning of the Trust Indenture Act, the
trustee shall either eliminate such interest or resign in the manner provided by the indentures. Any resignation will require the
appointment of a successor trustee under the applicable indenture in accordance with its terms and conditions.
The trustee may resign with respect to one
or more series of debt securities and a successor trustee may be appointed by us to act with respect to any such series. The trustee
may be removed with respect to a series of debt securities by the Company in accordance with the terms of the Indenture, or by
the holders of a majority in aggregate principal amount of such series at any time (Section 610).
Each indenture contains certain limitations
on the right of the trustee thereunder, in the event that it becomes our creditor, to obtain payment of claims in some cases, or
to realize on property received in respect of any such claim, as security or otherwise (Section 613).
The trustee is required to submit an annual
report to the holders of the debt securities regarding, among other things, the trustee’s eligibility to serve, the priority
of the trustee’s claims regarding certain advances made by it, and any action taken by the trustee materially affecting the
debt securities. However, no annual report is required to be submitted if no event described in Section 313(a) of the Trust Indenture
Act has occurred within the 12 months preceding the reporting date (Section 703).
Each indenture provides that, in addition
to other certificates or opinions that may be specifically required by other provisions of an indenture, every application by us
for action by the trustee shall be accompanied by a certificate of our officers and an opinion of counsel, who may be our counsel,
stating that, in the opinion of the signers, we have complied with all conditions precedent to the action (Section 102).
No Personal Liability of Officers, Directors, Employees
or Shareholders
Our officers, directors, employees and shareholders
will not have any liability for our obligations under the indentures or the debt securities by way of his or her status. Each holder
of debt securities, by accepting a debt security, waives and releases all such liability. The waiver and release are part of the
consideration for the issuance of the debt securities.
Form, Denominations and Registration; Global Securities;
Book Entry Only System
Unless otherwise indicated in a prospectus
supplement, the debt securities of a series will be issued only in fully registered form, without coupons, in minimum denominations
of $1,000 or integral multiples in excess thereof (Section 302). You will not have to pay a service charge to transfer or exchange
debt securities of a series, but we may require you to pay for taxes or other governmental charges due upon a transfer or exchange
(Section 305).
Unless otherwise indicated in a prospectus
supplement, each series of debt securities will be deposited with, or on behalf of, The Depository Trust Company (“DTC”)
or any successor depositary, which we call a “depositary,” and will be represented by one or more global notes registered
in the name of Cede & Co., as nominee of DTC. The interests of beneficial owners in the global notes will be represented through
financial institutions acting on their behalf as direct or indirect participants in DTC. See “
Global Securities
”
for the procedures for transfer of interests in securities held in global form.
Description of Common Stock
We are authorized to issue 42,000,000 shares
of capital stock, 40,000,000 of which are shares of common stock, par value of $0.01 per share, and 2,000,000 of which are shares
of preferred stock, par value of $0.01 per share. As of December 31, 2018, we had 19,790,884 shares of common stock outstanding,
and no shares of preferred stock outstanding.
Each share of common stock has the same relative rights as,
and is identical in all respects to, each other share of common stock.
Dividends
The holders of our common stock are entitled
to receive and share equally in such dividends, if any, declared by the board of directors out of funds legally available therefor.
Under the New York Business Corporation Law, we may pay dividends on our outstanding shares except when the Company is insolvent
or would be made insolvent by the dividend. In addition, we may pay dividends and other distributions either (1) out of surplus,
so that our net assets remaining after such payment or distribution shall at least equal the amount of our stated capital, or (2)
if we have no such surplus, out of our net profits for the fiscal year in which the dividend is declared and/or the preceding fiscal
year; provided, that, if our capital is less than the aggregate amount of the stated capital represented by the issued and outstanding
shares of all classes having a preference upon the distribution of assets, we may not pay dividends out of such net profits until
the deficiency in the amount of stated capital represented by the issued and outstanding shares of all classes having a preference
upon the distribution of assets shall have been repaired. If we issue preferred stock, the holders thereof may have a priority
over the holders of our common stock with respect to dividends.
Voting Rights
The holders of our common stock are generally entitled to one
vote per share. Holders of our common stock are not entitled to cumulate their votes in the election of directors.
Liquidation
In the event of our liquidation, dissolution
or winding up, the holders of our common stock would be entitled to receive, after payment or provision for payment of all our
debts and liabilities and the holders of any preferred stock, all of our assets available for distribution.
No Preemptive or Redemption Rights
Holders of our common stock are not
entitled to preemptive rights with respect to any shares that may be issued. The common stock is not subject to redemption.
Provisions in Our Certificate of Incorporation, Our Bylaws
and Federal Law Affecting Our Shareholders
Our certificate of incorporation and bylaws
contain a number of provisions relating to corporate governance and rights of shareholders that might discourage future takeover
attempts. As a result, shareholders who might desire to participate in such transactions may not have an opportunity to do so.
In addition, these provisions will also render the removal of our board of directors or management more difficult. Such provisions
include, among others, the requirement of a supermajority vote of shareholders to approve certain business combinations and other
corporate actions, special procedural rules for certain business combinations, a classified board of directors, restrictions on
the calling of special meetings of shareholders that do not provide for the calling of special meetings by the shareholders, and
a provision in our certificate of incorporation allowing the board of directors to oppose a tender or other offer for our securities,
including through the issuance of authorized but unissued securities or treasury stock or granting stock options, based on a wide
range of considerations. The foregoing is qualified in its entirety by reference to our certificate of incorporation and bylaws,
both of which are on file with the SEC.
The Bank Holding Company Act generally would
prohibit any company that is not engaged in financial activities and activities that are permissible for a bank holding company
or a financial holding company from acquiring control of us. “Control” is generally defined as ownership of 25% or
more of the voting stock or other exercise of a controlling influence. In addition, any existing bank holding company would need
the prior approval of the Federal Reserve before acquiring 5% or more of our voting stock. The Change in Bank Control Act of 1978,
as amended, prohibits a person or group of persons from acquiring control of a bank holding company unless the Federal Reserve
has been notified and has not objected to the transaction. Under a rebuttable presumption established by the Federal Reserve, the
acquisition of 10% or more of a class of voting stock of a bank holding company with a class of securities registered under Section
12 of the Exchange Act, such as us, could constitute acquisition of control of the bank holding company.
Description of Preferred Stock
The following summary contains a description
of the general terms of the preferred stock that we may issue. The specific terms of any series of preferred stock will be described
in the prospectus supplement relating to that series of preferred stock. The terms of any series of preferred stock may differ
from the terms described below. Certain provisions of the preferred stock described below and in any prospectus supplement are
not complete. You should refer to the amendment to our certificate of incorporation or the certificate of amendment pursuant to
applicable New York State law with respect to the establishment of a series of preferred stock which will be filed with the SEC
in connection with the offering of such series of preferred stock.
General
Our certificate of incorporation permits
our board of directors to authorize the issuance of up to 2,000,000 shares of preferred stock, par value $0.01, in one or more
series, without stockholder action. The board of directors can fix the number of shares to be included in each such series, and
the designation, powers, preferences, and rights of the shares of each such series and any qualifications, limitations or restrictions
thereof. Therefore, without stockholder approval, our board of directors can authorize the issuance of preferred stock with voting,
dividend, liquidation and conversion and other rights that could dilute the voting power of the common stock and may assist management
in impeding any unfriendly takeover or attempted change in control. None of our preferred stock is currently outstanding.
The preferred stock has the terms described
below unless otherwise provided in the prospectus supplement relating to a particular series of the preferred stock. You should
read the prospectus supplement relating to the particular series of the preferred stock being offered for specific terms, including:
|
|
·
|
the designation and stated value per share of the preferred stock
and the number of shares offered;
|
|
|
·
|
the amount of liquidation preference per share;
|
|
|
·
|
the price at which the preferred stock will be issued;
|
|
|
·
|
the dividend rate, or method of calculation, the dates on which dividends
will be payable, whether dividends will be cumulative or noncumulative and, if cumulative, the dates from which dividends will
commence to accumulate;
|
|
|
·
|
any redemption or sinking fund provisions;
|
|
|
·
|
any conversion provisions; and
|
|
|
·
|
any
other rights, preferences, privileges, limitations and restrictions on the preferred stock.
|
The preferred stock will, when issued,
be fully paid and nonassessable. Unless otherwise specified in the prospectus supplement, each series of the preferred stock will
rank equally as to dividends and liquidation rights in all respects with each other series of preferred stock. The rights of holders
of shares of each series of preferred stock will be subordinate to those of our general creditors.
We may, at our option, with respect to
any series of the preferred stock, elect to offer fractional interests in shares of preferred stock, which we call depositary shares.
See
“Description of Depositary Shares”
below.
Rank
Any series of the preferred stock will, with respect to the
priority of the payment of dividends and the priority of payments upon liquidation, winding up and dissolution, rank:
|
|
·
|
senior to all classes of common stock and all equity securities issued
by us the terms of which specifically provide that the equity securities will rank junior to the preferred stock (the junior securities);
|
|
|
·
|
equally with all equity securities issued by us the terms of which
specifically provide that the equity securities will rank equally with the preferred stock (the parity securities); and
|
|
|
·
|
junior
to all equity securities issued by us the terms of which specifically provide that the equity securities will rank senior to the
preferred stock.
|
Dividends
Holders of the preferred stock of each
series will be entitled to receive, when, as and if declared by our board of directors, cash dividends at such rates and on such
dates described, if any, in the prospectus supplement. Different series of preferred stock may be entitled to dividends at different
rates or based on different methods of calculation. The dividend rate may be fixed or variable or both. Dividends will be payable
to the holders of record as they appear on our stock books on record dates fixed by our board of directors, as specified in the
applicable prospectus supplement.
Dividends on any series of the preferred
stock may be cumulative or noncumulative, as described in the applicable prospectus supplement. If our board of directors does
not declare a dividend payable on a dividend payment date on any series of noncumulative preferred stock, then the holders of that
noncumulative preferred stock will have no right to receive a dividend for that dividend payment date, and we will have no obligation
to pay the dividend accrued for that period, whether or not dividends on that series are declared payable on any future dividend
payment dates. Dividends on any series of cumulative preferred stock will accrue from the date we initially issue shares of such
series or such other date specified in the applicable prospectus supplement.
No full dividends may be declared or paid
or funds set apart for the payment of any dividends on any parity securities unless dividends have been paid or set apart for payment
on the preferred stock. If full dividends are not paid, the preferred stock will share dividends pro rata with the parity securities.
No dividends may be declared or paid or funds set apart for the payment of dividends on any junior securities unless full cumulative
dividends for all dividend periods terminating on or prior to the date of the declaration or payment will have been paid or declared
and a sum sufficient for the payment set apart for payment on the preferred stock.
Our ability to pay dividends on our preferred
stock is limited by the New York State Business Corporation Law.
Rights Upon Liquidation
If we dissolve, liquidate or wind up our
affairs, either voluntarily or involuntarily, the holders of each series of preferred stock will be entitled to receive, before
any payment or distribution of assets is made to holders of junior securities, liquidating distributions in the amount described
in the prospectus supplement relating to that series of the preferred stock, plus an amount equal to accrued and unpaid dividends
and, if the series of the preferred stock is cumulative, for all dividend periods prior to that point in time. If the amounts payable
with respect to the preferred stock of any series and any other parity securities are not paid in full, the holders of the preferred
stock of that series and of the parity securities will share proportionately in the distribution of our assets in proportion to
the full liquidation preferences to which they are entitled. After the holders of preferred stock and the parity securities are
paid in full, they will have no right or claim to any of our remaining assets.
Because we are a bank holding company, our
rights, the rights of our creditors and of our stockholders, including the holders of the preferred stock offered by this prospectus,
to participate in the assets of any subsidiary upon the subsidiary’s liquidation or recapitalization may be subject to the
prior claims of the subsidiary’s creditors except to the extent that we may ourselves be a creditor with recognized claims
against the subsidiary.
Redemption
We may provide that a series of the preferred
stock may be redeemable, in whole or in part, at our option. In addition, a series of preferred stock may be subject to mandatory
redemption pursuant to a sinking fund or otherwise. The redemption provisions that may apply to a series of preferred stock, including
the redemption dates and the redemption prices for that series, will be described in the prospectus supplement.
In the event of partial redemptions of
preferred stock, whether by mandatory or optional redemption, our board of directors will determine the method for selecting the
shares to be redeemed, which may be by lot or pro rata or by any other method determined to be equitable.
On or after a redemption date, unless
we default in the payment of the redemption price, dividends will cease to accrue on shares of preferred stock called for redemption.
In addition, all rights of holders of the shares will terminate except for the right to receive the redemption price.
Unless otherwise specified in the applicable prospectus supplement
for any series of preferred stock, if any dividends on any other series of preferred stock ranking equally as to payment of dividends
and liquidation rights with such series of preferred stock are in arrears, no shares of any such series of preferred stock may
be redeemed, whether by mandatory or optional redemption, unless all shares of preferred stock are redeemed, and we will not purchase
any shares of such series of preferred stock. This requirement, however, will not prevent us from acquiring such shares pursuant
to a purchase or exchange offer made on the same terms to holders of all such shares outstanding.
Voting Rights
Unless otherwise described in the applicable
prospectus supplement, holders of the preferred stock will have no voting rights except as otherwise required by law or in our
certificate of incorporation.
Exchangeability
The terms on which shares of preferred stock of any series may
be converted into or exchanged for another class or series of securities will be described in the applicable prospectus supplement.
Unless otherwise indicated in a prospectus
supplement, each series of preferred stock may be deposited with, or on behalf of, DTC or any successor depositary and represented
by one or more global securities registered in the name of Cede & Co., as nominee of DTC. The interests of beneficial owners
in the global securities will be represented through financial institutions acting on their behalf as direct or indirect participants
in DTC. See
“Global Securities”
for the procedures for transfer of interests in securities held in global form.
Description of Depositary Shares
General
We may, at our option, elect to offer
depositary shares, which represent an interest in fractional shares of preferred stock, rather than full shares of preferred stock.
If we do, we will issue to the public receipts, called depositary receipts, for depositary shares, each of which will represent
a fraction, to be described in the prospectus supplement, of a share of a particular series of preferred stock.
The shares of any series of preferred
stock represented by depositary shares will be deposited with a depositary named in the prospectus supplement. Unless otherwise
provided in the prospectus supplement, each owner of a depositary share will be entitled, in proportion to the applicable fractional
interest in a share of preferred stock represented by the depositary share, to all the rights and preferences of the preferred
stock represented by the depositary share. Those rights include dividend, voting, redemption, conversion and liquidation rights.
Dividends and Other Distributions
The depositary will distribute all cash
dividends or other cash distributions received in respect of the preferred stock to the record holders of depositary shares in
proportion to the numbers of depositary shares owned by those holders.
If there is a distribution other than
in cash, the depositary will distribute property received by it to the record holders of depositary shares, unless the depositary
determines that it is not feasible to make the distribution. If this occurs, the depositary may, with our approval, sell the property
and distribute the net proceeds from the sale to the holders.
Withdrawal of Stock
Unless the related depositary shares have
been previously called for redemption, upon surrender of the depositary receipts at the office of the depositary, the holder of
the depositary shares will be entitled to delivery, at the office of the depositary to or upon his or her order, of the number
of whole shares of the preferred stock and any money or other property represented by the depositary shares. If the depositary
receipts delivered by the holder evidence a number of depositary shares in excess of the number of depositary shares representing
the number of whole shares of preferred stock to be withdrawn, the depositary will deliver to the holder at the same time a new
depositary receipt evidencing the excess number of depositary shares. In no event will the depositary deliver fractional shares
of preferred stock upon surrender of depositary receipts.
Redemption of Depositary Shares
Whenever we redeem shares of preferred
stock held by the depositary, the depositary will redeem as of the same redemption date the number of depositary shares representing
shares of the preferred stock so redeemed, so long as we have paid in full to the depositary the redemption price of the preferred
stock to be redeemed plus an amount equal to any accumulated and unpaid dividends on the preferred stock to the date fixed for
redemption. The redemption price per depositary share will be equal to the redemption price and any other amounts per share payable
on the preferred stock multiplied by the fraction of a share of preferred stock represented by one depositary share. If less than
all the depositary shares are to be redeemed, the depositary shares to be redeemed will be selected by lot or pro rata or by any
other equitable method as may be determined by the depositary.
After the date fixed for redemption, depositary
shares called for redemption will no longer be deemed to be outstanding and all rights of the holders of depositary shares will
cease, except the right to receive the moneys payable upon redemption and any money or other property to which the holders of the
depositary shares were entitled upon redemption upon surrender to the depositary of the depositary receipts evidencing the depositary
shares.
Voting the Depositary Shares
Upon receipt of notice of any meeting at
which the holders of the preferred stock are entitled to vote, the depositary will mail the information contained in the notice
of meeting to the record holders of the depositary receipts relating to that preferred stock. The record date for the depositary
receipts relating to the preferred stock will be the same date as the record date for the preferred stock. Each record holder of
the depositary shares on the record date will be entitled to instruct the depositary as to the exercise of the voting rights pertaining
to the number of shares of preferred stock represented by that holder’s depositary shares. The depositary will endeavor,
insofar as practicable, to vote the number of shares of preferred stock represented by the depositary shares in accordance with
those instructions, and we will agree to take all action which may be deemed necessary by the depositary in order to enable the
depositary to do so. The depositary will not vote any shares of preferred stock except to the extent it receives specific instructions
from the holders of depositary shares representing that number of shares of preferred stock.
Charges of Depositary
We will pay all transfer and other taxes
and governmental charges arising solely from the existence of the depositary arrangements. We will pay charges of the depositary
in connection with the initial deposit of the preferred stock and any redemption of the preferred stock. Holders of depositary
receipts will pay other transfer and other taxes and governmental charges and such other charges as are expressly provided in the
deposit agreement to be for their accounts.
Resignation and Removal of Depositary
The depositary may resign at any time by
delivering to us notice of its election to do so, and we may remove the depositary at any time. Any resignation or removal of the
depositary will take effect upon our appointment of a successor depositary and its acceptance of such appointment. The successor
depositary must be appointed within 60 days after delivery of the notice of resignation or removal and must be a bank or trust
company having its principal office in the United States and having a combined capital and surplus of at least $50,000,000.
Notices
The depositary will forward to holders
of depositary receipts all notices, reports and other communications, including proxy solicitation materials received from us,
which are delivered to the depositary and which we are required to furnish to the holders of the preferred stock.
Limitation of Liability
Neither we, the trustee or its agents,
nor the depositary will be liable if either of us is prevented or delayed by law or any circumstance beyond our control in performing
our obligations. Our obligations and those of the depositary will be limited to performance in good faith of our and their duties
thereunder. We and the depositary will not be obligated to prosecute or defend any legal proceeding in respect of any depositary
shares or preferred stock unless satisfactory indemnity is furnished. We and the depositary may rely upon written advice of counsel
or accountants, on information provided by persons presenting preferred stock for deposit, holders of depositary receipts or other
persons believed to be competent and on documents believed to be genuine.
Description of Warrants
We may issue warrants to purchase debt
securities, preferred stock, depositary shares or common stock. We may offer warrants separately or together with one or more additional
warrants, debt securities, preferred stock, depositary shares or common stock, or any combination of those securities in the form
of units, as described in the appropriate prospectus supplement. If we issue warrants as part of a unit, the accompanying prospectus
supplement will specify whether those warrants may be separated from the other securities in the unit prior to the warrants’
expiration date. Below is a description of certain general terms and provisions of the warrants that we may offer. Further terms
of the warrants will be described in the prospectus supplement.
The applicable prospectus supplement will
contain, where applicable, the following terms of and other information relating to the warrants:
|
|
·
|
the specific designation and aggregate number of, and
the price at which we will issue, the warrants;
|
|
|
·
|
the currency or currency units in which the offering
price, if any, and the exercise price are payable;
|
|
|
·
|
the date on which the right to exercise the warrants
will begin and the date on which that right will expire or, if you may not continuously exercise the warrants throughout that
period, the specific date or dates on which you may exercise the warrants;
|
|
|
·
|
any applicable antidilution provisions;
|
|
|
·
|
any applicable redemption or call provisions;
|
|
|
·
|
the circumstances under which the warrant exercise price
may be adjusted;
|
|
|
·
|
whether the warrants will be issued in fully registered
form or bearer form, in definitive or global form or in any combination of these forms, although, in any case, the form of a warrant
included in a unit will correspond to the form of the unit and of any security included in that unit;
|
|
|
·
|
any applicable material United States federal income
tax consequences;
|
|
|
·
|
the identity of the warrant agent for the warrants and
of any other depositaries, execution or paying agents, transfer agents, registrars or other agents;
|
|
|
·
|
the proposed listing, if any, of the warrants or any
securities purchasable upon exercise of the warrants on any securities exchange;
|
|
|
·
|
the designation and terms of the debt securities, preferred
stock, depositary shares or common stock purchasable upon exercise of the warrants;
|
|
|
·
|
the designation, aggregate principal amount, currency
and terms of the debt securities that may be purchased upon exercise of the warrants;
|
|
|
·
|
if applicable, the designation and terms of the debt
securities, preferred stock, depositary shares or common stock with which the warrants are issued and the number of warrants issued
with each security;
|
|
|
·
|
if applicable, the date from and after which the warrants
and the related debt securities, preferred stock, depositary shares or common stock will be separately transferable;
|
|
|
·
|
the principal amount of debt securities, the number of
shares of preferred stock, the number of depositary shares or the number of shares of common stock purchasable upon exercise of
a warrant and the price at which those shares may be purchased;
|
|
|
·
|
if applicable, the minimum or maximum amount of the warrants
that may be exercised at any one time;
|
|
|
·
|
information with respect to book-entry procedures, if
any;
|
|
|
·
|
whether the warrants are to be sold separately or with
other securities as parts of units; and
|
|
|
·
|
any additional terms of the warrants, including terms,
procedures and limitations relating to the exchange and exercise of the warrants.
|
Description of Purchase Contracts
We may issue purchase contracts, including
purchase contracts issued as part of a unit with one or more other securities, for the purchase or sale of our debt securities,
preferred stock, depositary shares or common stock. The price of our debt securities or price per share of common stock, preferred
stock or depositary shares, as applicable, may be fixed at the time the purchase contracts are issued or may be determined by reference
to a specific formula contained in the purchase contracts. We may issue purchase contracts in such amounts and in as many distinct
series as we wish.
The applicable prospectus supplement may
contain, where applicable, the following information about the purchase contracts issued under it:
|
|
·
|
whether the purchase contracts obligate the holder to purchase or sell, or both, our debt securities, common stock, preferred
stock or depositary shares, as applicable, and the nature and amount of each of those securities, or method of determining those
amounts;
|
|
|
·
|
whether the purchase contracts are to be prepaid or not;
|
|
|
·
|
whether the purchase contracts are to be settled by delivery, or by reference or linkage to the value, performance or level
of our common stock or preferred stock;
|
|
|
·
|
any acceleration, cancellation, termination or other provisions relating to the settlement of the purchase contracts;
|
|
|
·
|
United States federal income tax considerations relevant to the purchase contracts; and
|
|
|
·
|
whether the purchase contracts will be issued in fully
registered global form.
|
The applicable prospectus supplement will
describe the terms of any purchase contracts. The preceding description and any description of purchase contracts in the applicable
prospectus supplement does not purport to be complete and is subject to and is qualified in its entirety by reference to the purchase
contract agreement and, if applicable, collateral arrangements and depositary arrangements relating to such purchase contracts.
Description of Units
We may issue units comprised of two or
more of the other securities described in this prospectus in any combination. Each unit will be issued so that the holder of the
unit is also the holder of each security included in the unit. Thus, the holder of a unit will have the rights and obligations
of a holder of each included security. The unit agreement under which a unit is issued may provide that the securities included
in the unit may not be held or transferred separately, at any time or at any time before a specified date.
The applicable prospectus supplement may
describe:
|
|
·
|
the designation and terms of the units and of the securities
comprising the units, including whether and under what circumstances those securities may be held or transferred separately;
|
|
|
·
|
any provisions for the issuance, payment, settlement,
transfer or exchange of the units or of the securities comprising the units;
|
|
|
·
|
the terms of the unit agreement governing the units;
|
|
|
·
|
United States federal income tax considerations relevant
to the units; and
|
|
|
·
|
whether the units will be issued in fully registered
or global form.
|
The preceding description and any description
of units in the applicable prospectus supplement does not purport to be complete and is subject to and is qualified in its entirety
by reference to the form of unit agreement which will be filed with the SEC in connection with the offering of such units, and,
if applicable, collateral arrangements and depositary arrangements relating to such units.
Description of Subscription Rights
General
We may distribute subscription rights, which
may or may not be transferable, to the holders of our common stock, holders of any series of our preferred stock, holders of depository
shares or holders of our debt securities as of a record date set by our board of directors, at no cost to such holders. Each holder
will be given the right to purchase a specified number of whole shares of our common stock, preferred stock, depository shares
or debt securities for every share of our common stock, share of a series of preferred stock, depository shares or our debt securities
that the holder thereof owned on such record date, as set forth in the applicable prospectus supplement. The subscription rights
will be evidenced by subscription rights certificates, which may be in definitive or book-entry form. Each right will entitle the
holder to purchase shares of our common stock, a series of preferred stock, depository shares or our debt securities at a rate
and price to be established by our board of directors, as set forth in the applicable prospectus supplement. If holders of rights
wish to exercise their subscription rights, they must do so before the expiration date of the subscription rights offering, as
set forth in the applicable prospectus supplement. Upon the expiration date, the subscription rights will expire and will no longer
be exercisable, unless, in our sole discretion prior to the expiration date, we extend the subscription rights offering.
Exercise Price
Our board of directors will determine the
exercise price or prices for the subscription rights based upon a number of factors, including, without limitation, our business
prospects; our capital requirements; the price or prices at which an underwriter or standby purchasers may be willing to purchase
securities that remain unsold in the subscription rights offering; and general conditions in the securities markets, especially
for securities of financial institutions.
The subscription price may or may not reflect
the actual or long-term fair value of the common stock, preferred stock, depository shares or debt securities offered in the subscription
rights offering. We provide no assurances as to the market values or liquidity of any subscription rights issued, or as to whether
or not the market prices of the common stock, preferred stock, depository shares or debt securities subject to the subscription
rights will be more or less than the subscription rights’ exercise price during the term of the rights or after the rights
expire.
Exercising Rights; Fees and Expenses
The manner of exercising subscription rights
will be set forth in the applicable prospectus supplement. Any subscription agent or escrow agent will be set forth in the applicable
prospectus supplement. We will pay all fees charged by any subscription agent and escrow agent in connection with the distribution
and exercise of subscription rights. Subscription rights holders will be responsible for paying all other commissions, fees, taxes
or other expenses incurred in connection with their transfer of subscription rights that are transferable. Neither we nor the subscription
agent will pay such expenses.
Expiration of Rights
The applicable prospectus supplement will
set forth the expiration date and time (“Expiration Date”) for exercising subscription rights. If holders of subscription
rights do not exercise their subscription rights prior to such time, their subscription rights will expire and will no longer be
exercisable and will have no value. We will extend the Expiration Date as required by applicable law and may, in our sole discretion,
extend the Expiration Date. If we elect to extend the Expiration Date, we will issue a press release announcing such extension
prior to the scheduled Expiration Date.
Withdrawal and Termination
We may withdraw the subscription rights
offering at any time prior to the Expiration Date for any reason. We may terminate the subscription rights offering, in whole or
in part, at any time before completion of the subscription rights offering if there is any judgment, order, decree, injunction,
statute, law or regulation entered, enacted, amended or held to be applicable to the subscription rights offering that in the sole
judgment of our board of directors would or might make the subscription rights offering or its completion, whether in whole or
in part, illegal or otherwise restrict or prohibit completion of the subscription rights offering. We may waive any of these conditions
and choose to proceed with the subscription rights offering even if one or more of these events occur. If we terminate the subscription
rights offering, in whole or in part, all affected rights will expire without value, and all subscription payments received by
the subscription agent will be returned promptly without interest.
Rights of Subscribers
Holders of subscription rights will have
no rights as holders with respect to our common stock, preferred stock, depository shares or debt securities for which the rights
may be exercised until they have exercised their rights by payment in full of the exercise price and in the manner provided in
the applicable prospectus supplement, and such common stock, preferred stock, depository shares or debt securities, as applicable,
have been issued to such persons. Holders of subscription rights will have no right to revoke their subscriptions or receive their
monies back after they have completed and delivered the materials required to exercise their subscription rights and have paid
the exercise price to the subscription agent. All exercises of rights will be final and cannot be revoked by the holder of rights.
Regulatory Limitations
We will not be required to issue any person
or group of persons shares of our common stock, preferred stock, depository shares or debt securities pursuant to the subscription
rights offering if, in our sole opinion, such person would be required to give prior notice to or obtain prior approval from, any
state or federal governmental authority to own or control such securities if, at the time the rights offering is scheduled to expire,
such person has not obtained such clearance or approval in form and substance reasonably satisfactory to us.
Standby Agreements
We may enter into one or more separate agreements
with one or more standby underwriters or other persons to purchase, for their own account or on our behalf, our common stock, preferred
stock, depository shares or debt securities not subscribed for in the subscription rights offering. The terms of any such agreements
will be described in the applicable prospectus supplement.
GLOBAL SECURITIES
Unless otherwise indicated in the applicable
prospectus supplement, securities other than common stock will be issued in the form of one or more global certificates, or “global
securities,” registered in the name of a depositary or its nominee. Unless otherwise indicated in the applicable prospectus
supplement, the depositary will be DTC and the securities will be registered in the name of Cede & Co. No person that acquires
a beneficial interest in those securities will be entitled to receive a certificate representing that person’s interest in
the securities except as described herein or in the applicable prospectus supplement. Unless and until definitive securities are
issued under the limited circumstances described below, all references to actions by holders of securities issued in global form
will refer to actions taken by DTC upon instructions from its participants, and all references to payments and notices to holders
will refer to payments and notices to DTC or Cede & Co., as the registered holder of these securities.
DTC is a limited-purpose trust company organized
under the New York Banking Law, a “banking organization” within the meaning of the New York Banking Law, a member of
the Federal Reserve System, a “clearing corporation” within the meaning of the New York Uniform Commercial Code, and
a “clearing agency” registered pursuant to the provisions of Section 17A of the Exchange Act. DTC holds securities
that DTC participants deposit with DTC. DTC also facilitates the settlement among DTC participants of securities transactions,
such as transfers and pledges, in deposited securities through electronic computerized book-entry changes in DTC participants’
accounts, thereby eliminating the need for physical movement of certificates. DTC participants include securities brokers and dealers,
banks, trust companies and clearing corporations, and may include other organizations. DTC is a wholly owned subsidiary of the
Depository Trust & Clearing Corporation, or DTCC. DTCC, in turn, is owned by a number of DTC’s participants and subsidiaries
of DTCC as well as by the New York Stock Exchange, Inc., the American Stock Exchange, LLC and the Financial Industry Regulatory
Authority, Inc. Indirect access to the DTC system also is available to others such as banks, brokers, dealers and trust companies
that clear through or maintain a custodial relationship with a participant, either directly or indirectly. The rules applicable
to DTC and DTC participants are on file with the SEC.
Persons that are not participants or indirect
participants but desire to purchase, sell or otherwise transfer ownership of, or other interests in, securities may do so only
through participants and indirect participants. Under a book-entry format, holders may experience some delay in their receipt of
payments, as such payments will be forwarded by our designated agent to Cede & Co., as nominee for DTC. DTC will forward such
payments to its participants, who will then forward them to indirect participants or holders. Holders will not be recognized by
the relevant registrar, transfer agent, trustee or warrant agent as registered holders of the securities entitled to the benefits
of our certificate of incorporation or the applicable indenture, warrant agreement or other applicable security. Beneficial owners
that are not participants will be permitted to exercise their rights only indirectly through and according to the procedures of
participants and, if applicable, indirect participants.
Under the rules, regulations and procedures
creating and affecting DTC and its operations as currently in effect, DTC will be required to make book-entry transfers of securities
among participants and to receive and transmit payments to participants. DTC rules require participants and indirect participants
with which beneficial securities owners have accounts to make book-entry transfers and receive and transmit payments on behalf
of their respective account holders.
Because DTC can act only on behalf of participants,
who in turn act only on behalf of participants or indirect participants, and certain banks, trust companies and other persons approved
by it, the ability of a beneficial owner of securities issued in global form to pledge such securities to persons or entities that
do not participate in the DTC system may be limited due to the unavailability of physical certificates for these securities.
DTC will take any action permitted to be
taken by a registered holder of any securities under our certificate of incorporation or the relevant indenture, warrant agreement,
or other applicable security only at the direction of one or more participants to whose accounts with DTC such securities are credited.
Unless otherwise indicated in the applicable
prospectus supplement, a global security will be exchangeable for the relevant definitive securities registered in the names of
persons other than DTC or its nominee only if:
|
|
Ÿ
|
DTC notifies us that it is unwilling or unable to continue as depositary for that global security or if DTC ceases to be a
clearing agency registered under the Exchange Act when DTC is required to be so registered;
|
|
|
Ÿ
|
we execute and deliver to the relevant registrar, transfer agent, trustee and/or warrant agent an order complying with the
requirements of the applicable indenture, warrant agreement, or other security that the global security will be exchangeable for
definitive securities in registered form; or
|
|
|
Ÿ
|
there has occurred and is continuing a default in the payment of any amount due in respect of the securities or, in the case
of debt securities, an event of default or an event that, with the giving of notice or lapse of time, or both, would constitute
an event of default with respect to these debt securities.
|
Any global security that is exchangeable
under the preceding sentence will be exchangeable for securities registered in such names as DTC directs.
Upon the occurrence of any event described
in the preceding paragraph, DTC is generally required to notify all participants of the availability of definitive securities.
Upon DTC surrendering the global security representing the securities and delivery of instructions for re-registration, the registrar,
transfer agent, trustee or warrant agent, as the case may be, will reissue the securities as definitive securities, and then such
persons will recognize the holders of such definitive securities as registered holders of securities entitled to the benefits of
our certificate of incorporation or the relevant indenture, warrant agreement or other security.
Redemption notices will be sent to Cede
& Co. as the registered holder of the global securities. If less than all of a series of securities are being redeemed, DTC
will determine the amount of the interest of each direct participant to be redeemed in accordance with its then current procedures.
Except as described above, the global security
may not be transferred except as a whole by DTC to a nominee of DTC or by a nominee of DTC to DTC or another nominee of DTC or
to a successor depositary we appoint. Except as described above, DTC may not sell, assign, transfer or otherwise convey any beneficial
interest in a global security evidencing all or part of any securities unless the beneficial interest is in an amount equal to
an authorized denomination for these securities.
The information in this section concerning
DTC and DTC’s book-entry system has been obtained from sources that we believe to be accurate, but we assume no responsibility
for the accuracy thereof. None of us, any trustees, any registrar and transfer agent or any warrant agent, or any agent of any
of them, will have any responsibility or liability for any aspect of DTC’s or any participant’s records relating to,
or for payments made on account of, beneficial interests in a global security, or for maintaining, supervising or reviewing any
records relating to such beneficial interests.
Secondary trading in notes and debentures
of corporate issuers is generally settled in clearing-house or next-day funds. In contrast, beneficial interests in a global security,
in some cases, may trade in the DTC’s same-day funds settlement system, in which secondary market trading activity in those
beneficial interests would be required by DTC to settle in immediately available funds. There is no assurance as to the effect,
if any, that settlement in immediately available funds would have on trading activity in such beneficial interests. Also, settlement
for purchases of beneficial interests in a global security upon the original issuance of the security may be required to be made
in immediately available funds.
PLAN OF DISTRIBUTION
We may sell our securities
through underwriters or dealers, directly to purchasers, through agents, or through any combination thereof.
Each time that we use this prospectus
to sell our securities, we will also provide a prospectus supplement that contains the specific terms of the offering. The prospectus
supplement will set forth the terms of the offering of such stock, including:
|
|
Ÿ
|
the name or names of any underwriters, dealers or agents and the type
and amounts of securities underwritten or purchased by each of them;
|
|
|
Ÿ
|
the public offering price of the securities and the proceeds to us
and any discounts, commissions or concessions allowed or reallowed or paid to dealers; and
|
|
|
Ÿ
|
any public offering price and any discounts or concessions allowed
or reallowed or paid to dealers may be changed from time to time.
|
If underwriters are used in the sale of
any securities, the securities will be acquired by the underwriters for their own account and may be resold from time to time in
one or more transactions, including negotiated transactions, at a fixed public offering price or at varying prices determined at
the time of sale. The securities may be either offered to the public through underwriting syndicates represented by managing underwriters,
or directly by underwriters. Generally, the underwriters’ obligations to purchase the securities will be subject to certain
conditions precedent. The underwriters will be obligated to purchase all of the securities if they purchase any of the securities.
We may sell the securities through agents
from time to time. The prospectus supplement will name any agent involved in the offer or sale of our securities and any commissions
we pay to them. Generally, any agent will be acting on a best efforts basis for the period of its appointment.
We may authorize underwriters, dealers
or agents to solicit offers by certain purchasers to purchase our securities at the public offering price set forth in the prospectus
supplement pursuant to delayed delivery contracts providing for payment and delivery on a specified date in the future. The contracts
will be subject only to those conditions set forth in the prospectus supplement, and the prospectus supplement will set forth any
commissions or discounts we pay for solicitation of these contracts.
Agents and underwriters may be entitled
to indemnification by us against certain civil liabilities, including liabilities under the Securities Act of 1933, as amended,
or to contribution with respect to payments which the agents or underwriters may be required to make in respect thereof. Agents
and underwriters may be customers of, engage in transactions with, or perform services for us in the ordinary course of business.
We may enter into derivative transactions
with third parties, or sell securities not covered by this prospectus to third parties in privately negotiated transactions. If
the applicable prospectus supplement indicates in connection with those derivatives then the third parties may sell securities
covered by this prospectus and the applicable prospectus supplement, including in short sale transactions. If so, the third party
may use securities pledged by us or borrowed from us or others to settle those sales or to close out any related open borrowings
of stock, and may use securities received from us in settlement of those derivatives to close out any related open borrowings of
securities. The third party in such sale transactions will be an underwriter and will be identified in the applicable prospectus
supplement (or a post-effective amendment).
LEGAL OPINIONS
The validity of the securities offered
hereby will be passed upon for us by Luse Gorman, PC, Washington, D.C.
EXPERTS
The consolidated financial statements of
Bridge Bancorp, Inc. as of December 31, 2018 and 2017, and for each of the three years in the period ended December 31, 2018, and
the effectiveness of Bridge Bancorp, Inc.’s internal control over financial reporting as of December 31, 2018, have been
audited by Crowe LLP, an independent registered public accounting firm, as set forth in their report appearing in our Annual Report
on Form 10-K for the fiscal year ended December 31, 2018 and incorporated herein by reference. Such consolidated financial statements
have been so incorporated in reliance upon the report of such firm given upon their authority as experts in accounting and auditing.
PART II
INFORMATION NOT REQUIRED IN THE PROSPECTUS
Item 14. Other Expenses of Issuance
and Distribution.
Set forth below is
an estimate of the approximate amount of fees and expenses which we may incur in connection with the issuance and distribution
of the securities being registered, other than underwriting compensation.
|
Securities and Exchange Commission registration fee
|
|
$
|
24,240
|
|
|
Listing fees
|
|
|
*
|
|
|
Accounting fees and expenses
|
|
|
*
|
|
|
Legal fees and expenses
|
|
|
*
|
|
|
Blue Sky expenses
|
|
|
*
|
|
|
Printing
|
|
|
*
|
|
|
Trustee’s expenses
|
|
|
*
|
|
|
Fees of rating agencies
|
|
|
*
|
|
|
Transfer agent fees and expenses
|
|
|
*
|
|
|
Miscellaneous expenses
|
|
|
*
|
|
|
Total
|
|
$
|
*
|
|
__________________________
|
|
*
|
These fees and expenses depend on the securities offered
and the number of securities issuances and cannot be estimated at this time.
|
Item 15. Indemnification of Directors
and Officers.
Article V of the Registrant’s bylaws
provides as follows:
Section 501
-
Right to Indemnification
Any person who was, is, or is threatened
to be made a party to any action or proceeding, whether civil or criminal (including an action by or in the right of the Corporation
or any other corporation, partnership, joint venture, trust, employee benefit plan or other enterprise which any director or officer
of the Corporation served in any capacity at the request of this Corporation), by reason of the fact that he, his testator or intestate,
is or was a director or officer of the Corporation, or served such other corporation, partnership, joint venture, trust, employee
benefit plan or other enterprise in any capacity, shall be indemnified by the Corporation against all judgments, fines, amounts
paid in settlement and reasonable expenses, including attorneys’ fees actually and necessarily incurred in connection with
the defense or appeal of any such action or proceeding, and against any other amounts, expenses and fees similarly incurred; provided
that no indemnification shall be made to or on behalf of any director or officer where indemnification is prohibited by applicable
law. This right of indemnification shall include the right of a director or officer to receive payment from the Corporation for
expenses incurred in defending or appealing any such action or proceeding in advance of its final disposition; provided that the
payment of expenses in advance of the final disposition of an action or proceeding shall be made only upon delivery to the Corporation
of an undertaking by or on behalf of the director or officer to repay all amounts so advanced if it should be determined ultimately
that the director or officer is not entitled to be indemnified. The preceding right of indemnification shall be a contract right
enforceable by the director or officer with respect to any claim, cause of action, action or proceeding accruing or arising while
this Bylaw shall be in effect.
Section 502
-
Authorization of Indemnification
Any indemnification provided for by Section
501 shall be authorized in any manner provided by applicable law or, in the absence of such law;
|
|
(a)
|
By the Board of Directors acting by a quorum of directors
who are not parties to such action or proceeding, upon a finding that there has been no judgment or other final adjudication adverse
to the director or officer which establishes that his acts were committed in bad faith or were the result of active and deliberate
dishonesty and were material to the cause of action so adjudicated, or that he personally gained in fact a financial profit or
other advantage to which he was not legally entitled; or
|
|
|
(b)
|
If a quorum under clause (a) is not obtainable, (i) by the Board upon the opinion in writing of independent legal counsel that
indemnification is proper in the circumstances because there has been no such judgment or other final adjudication adverse to the
director or officer, or (ii) by the shareholders upon a finding that there has been no such judgment or other final adjudication
adverse to the director or officer.
|
Section 503
-
Right of Claimant to Bring Suit
If a claim of indemnification is not paid
in full by the Corporation within ninety days after a written claim has been received by the Corporation, the claimant may at any
time there- after bring suit against the Corporation to recover the unpaid amount of the claim and, if successful in whole or in
part, the claimant shall also be entitled to recover the expenses of prosecuting such claim.
Section 504
-
Non-Exclusivity of Rights
The rights conferred on any person under
this Article shall not be exclusive of any other right which may exist under any statute, provision of the Certificate of Incorporation,
Bylaw, agreement, vote of shareholders or disinterested directors or otherwise.
Section 505
–
Insurance
Subject to the laws of New York, the Corporation
may maintain insurance, as its expense, to protect itself and any director, officer, employee or agent of the Corporation against
any expense, liability or loss of the general nature contemplated by this Article, whether or not the Corporation would have the
power to indemnify such person against such expense, liability or loss under the laws of New York.
Section 506
–
Severability
It is the intent of the Corporation to indemnify
its officers and directors to the fullest extent authorized by the laws of New York as they now exist or may hereafter be amended.
If any portion of this Article shall for any reason be held invalid or unenforceable by judicial decision or legislative amendment,
the valid and enforceable provisions of this Article will continue to be given effect and shall be construed so as to provide the
broadest indemnification permitted by law.
Item 16. Exhibits.
The following
is a list of exhibits filed as part of the Registration Statement:
* To be filed by amendment or
incorporated by reference to a Current Report on Form 8-K.
Item 17. Undertakings.
The undersigned Registrant hereby undertakes:
(1) To file, during any period in which offers or sales are
being made, a post-effective amendment to this registration statement:
(i) To include any prospectus required by Section
10(a)(3) of the Securities Act of 1933;
(ii) To reflect in the prospectus any facts or events
arising after the effective date of the registration statement (or the most recent post-effective amendment thereof) which, individually
or in the aggregate, represent a fundamental change in the information set forth in the registration statement. Notwithstanding
the foregoing, any increase or decrease in volume of securities offered (if the total dollar value of securities offered would
not exceed that which was registered) and any deviation from the low or high end of the estimated maximum offering range may be
reflected in the form of prospectus filed with the Commission pursuant to Rule 424(b) if, in the aggregate, the changes in volume
and price represent no more than a 20 percent change in the maximum aggregate offering price set forth in the “Calculation
of Registration Fee” table in the effective registration statement; and
(iii) To include any material information with respect
to the plan of distribution not previously disclosed in the registration statement or any material change to such information in
the registration statement;
Provided, however,
that paragraphs (i), (ii)
and (iii) do not apply if the information required to be included in a post-effective amendment by those paragraphs is contained
in reports filed with or furnished to the Commission by the registrant pursuant to section 13 or section 15(d) of the Securities
Exchange Act of 1934 that are incorporated by reference in the registration statement, or is contained in a form of prospectus
filed pursuant to Rule 424(b) that is part of the registration statement.
(2) That, for the purpose of determining any liability under
the Securities Act of 1933, each such post-effective amendment shall be deemed to be a new registration statement relating to the
securities offered therein, and the offering of such securities at that time shall be deemed to be the initial bona fide offering
thereof.
(3) To remove from registration by means of a post-effective
amendment any of the securities being registered which remain unsold at the termination of the offering.
(4) That, for purposes of determining liability under the Securities
Act of 1933 to any purchaser:
(i) Each prospectus filed
by the registrant pursuant to Rule 424(b)(3) shall be deemed to be part of the registration statement as of the date the filed
prospectus was deemed part of and included in the registration statement; and
(ii) Each prospectus required
to be filed pursuant to Rule 424(b)(2), (b)(5) or (b)(7) as part of a registration statement in reliance on Rule 430B relating
to an offering made pursuant to Rule 415(a)(1)(i), (vii) or (x) for the purpose of providing the information required by section
10(a) of the Securities Act of 1933 shall be deemed to be part of and included in the registration statement as of the earlier
of the date such form of prospectus is first used after effectiveness or the date of the first contract of sale of securities in
the offering described in the prospectus. As provided in Rule 430B, for liability purposes of the issuer and any person that is
at that date an underwriter, such date shall be deemed to be a new effective date of the registration statement relating to the
securities in the registration statement to which that prospectus relates, and the offering of such securities at that time shall
be deemed to be the initial bona fide offering thereof.
Provided, however
, that no statement made in a registration statement
or prospectus that is part of the registration statement or made in a document incorporated or deemed incorporated by reference
into the registration statement or prospectus that is part of the registration statement will, as to a purchaser with a time of
contract of sale prior to such effective date, supersede or modify any statement that was made in the registration statement or
prospectus that was part of the registration statement or made in any such document immediately prior to such effective date.
(5) That, for the purpose of determining liability of the registrant
under the Securities Act of 1933 to any purchaser in the initial distribution of the securities, the undersigned registrant undertakes
that in a primary offering of securities of the registrant pursuant to this registration statement, regardless of the underwriting
method used to sell the securities to the purchaser, if the securities are offered or sold to such purchaser by means of any of
the following communications, the undersigned registrant will be a seller to the purchaser and will be considered to offer or sell
such securities to such purchaser:
(i) Any preliminary prospectus or prospectus of
the registrant relating to the offering required to be filed pursuant to Rule 424;
(ii) Any free writing prospectus relating to the
offering prepared by or on behalf of the registrant or used or referred to by the undersigned registrant;
(iii) The portion of any other free writing prospectus
relating to the offering containing material information about the undersigned registrant or its securities provided by or on behalf
of the undersigned registrant; and
(iv) Any other communication that is an offer in
the offering made by the registrant to the purchaser.
The undersigned registrant hereby undertakes that, for the purpose
of determining any liability under the Securities Act of 1933, each filing of the registrant’s annual report pursuant to
Section 13(a) or Section 15(d) of the Securities Exchange Act of 1934 (and, where applicable, each filing of an employee benefit
plan’s annual report pursuant to Section 15(d) of the Securities Exchange Act of 1934) that is incorporated by reference
in the registration statement shall be deemed to be a new registration statement relating to the securities offered therein, and
the offering of such securities at that time shall be deemed to be the initial bona fide offering thereof.
Insofar as indemnification for liabilities arising under the
Securities Act of 1933 may be permitted to directors, officers and controlling persons of the registrant pursuant to the foregoing
provisions, or otherwise, the registrant has been advised that in the opinion of the Securities and Exchange Commission such indemnification
is against public policy as expressed in the Securities Act of 1933 and is, therefore, unenforceable. In the event that a claim
for indemnification against such liabilities (other than the payment by the registrant of expenses incurred or paid by a director,
officer or controlling person of the registrant in the successful defense of any action, suit or proceeding) is asserted by such
director, officer or controlling person in connection with the securities being registered, the registrant will, unless in the
opinion of its counsel the matter has been settled by controlling precedent, submit to a court of appropriate jurisdiction the
question whether such indemnification by it is against public policy as expressed in the Securities Act of 1933 and will be governed
by the final adjudication of such issue.
SIGNATURES
Pursuant to the requirements
of the Securities Act of 1933, the Registrant certifies that it has reasonable grounds to believe that it meets all of the requirements
for filing on Form S-3 and has duly caused this Registration Statement on Form S-3 to be signed on its behalf by the undersigned,
thereunto duly authorized, in Bridgehampton, Town of Southampton, State of New York, on March 15, 2019.
|
|
|
BRIDGE BANCORP, INC.
|
|
|
|
|
|
|
|
|
By:
|
/s/ Kevin M. O’Connor
|
|
|
|
|
Kevin M. O’Connor
|
|
|
|
|
President and Chief Executive Officer
|
|
|
|
|
(Duly Authorized Representative)
|
POWER OF ATTORNEY
We, the undersigned directors
and officers of Bridge Bancorp, Inc. (the “Company”), hereby constitute and appoint Kevin M. O’Connor as our
true and lawful attorney and agent, to do any and all things in our names in the capacities indicated below which said Kevin M.
O’Connor may deem necessary or advisable to enable the Company to comply with the Securities Act of 1933, and any rules,
regulations and requirements of the Securities and Exchange Commission, in connection with this registration statement on Form
S-3 relating to the offering of the Company’s securities, including specifically, but not limited to, power and authority
to sign for us in our names in the capacities indicated below the registration statement and any and all amendments (including
post-effective amendments) thereto; and we hereby approve, ratify and confirm all that said Kevin M. O’Connor shall do or
cause to be done by virtue thereof.
Pursuant to the requirements
of the Securities Act of 1933, this Registration Statement on Form S-3 has been signed by the following persons in the capacities
and on the date indicated.
|
Signatures
|
|
Title
|
|
Date
|
|
|
|
|
|
|
|
/s/ Kevin M. O’Connor
|
|
President, Chief Executive Officer and
|
|
March 15, 2019
|
|
Kevin M. O’Connor
|
|
Director
|
|
|
|
|
|
|
|
|
|
/s/ John M. McCaffery
|
|
Executive Vice President, Chief Financial
|
|
March 15, 2019
|
|
John M. McCaffery
|
|
Officer and Treasurer
|
|
|
|
|
|
|
|
|
|
/s/ Nicholas Parrinelli
|
|
Vice President, Principal
|
|
March 15, 2019
|
|
Nicholas Parrinelli
|
|
Accounting Officer
|
|
|
|
|
|
|
|
|
|
/s/ Marcia Z. Hefter
|
|
Chairperson of the Board
|
|
March 15, 2019
|
|
Marcia Z. Hefter
|
|
|
|
|
|
/s/ Dennis A. Suskind
|
|
Vice Chairperson of the Board
|
|
March 15, 2019
|
|
Dennis A. Suskind
|
|
|
|
|
|
|
|
|
|
|
|
/s/ Emanuel Arturi
|
|
Director
|
|
March 15, 2019
|
|
Emanuel Arturi
|
|
|
|
|
|
|
|
|
|
|
|
/s/ Matthew Lindenbaum
|
|
Director
|
|
March 15, 2019
|
|
Matthew Lindenbaum
|
|
|
|
|
|
|
|
|
|
|
|
/s/ Charles I. Massoud
|
|
Director
|
|
March 15, 2019
|
|
Charles I. Massoud
|
|
|
|
|
|
|
|
|
|
|
|
/s/ Albert E. McCoy, Jr.
|
|
Director
|
|
March 15, 2019
|
|
Albert E. McCoy, Jr.
|
|
|
|
|
|
|
|
|
|
|
|
/s/ Raymond A. Nielsen
|
|
Director
|
|
March 15, 2019
|
|
Raymond A. Nielsen
|
|
|
|
|
|
|
|
|
|
|
|
/s/ Howard H. Nolan
|
|
Senior Executive Vice President,
|
|
March 15, 2019
|
|
Howard H. Nolan
|
|
Chief Operating Officer, Corporate Secretary and Director
|
|
|
|
|
|
|
|
|
|
/s/ Daniel Rubin
|
|
Director
|
|
March 15, 2019
|
|
Daniel Rubin
|
|
|
|
|
|
|
|
|
|
|
|
/s/ Rudolph J. Santoro
|
|
Director
|
|
March 15, 2019
|
|
Rudolph J. Santoro
|
|
|
|
|
|
|
|
|
|
|
|
Thomas J. Tobin
|
|
Director
|
|
|
|
|
|
|
|
|
|
/s/ Christian C. Yegen
|
|
Director
|
|
March 15, 2019
|
|
Christian C. Yegen
|
|
|
|
|
Bridge Bancorp (NASDAQ:BDGE)
Historical Stock Chart
From Mar 2024 to Apr 2024
Bridge Bancorp (NASDAQ:BDGE)
Historical Stock Chart
From Apr 2023 to Apr 2024
